GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Other Long Term Assets

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Other Long Term Assets : ¥128 Mil (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical Other Long Term Assets?

HPGC Renmintongtai Pharmaceutical's other long-term assets for the quarter that ended in Mar. 2024 was ¥128 Mil.

HPGC Renmintongtai Pharmaceutical's quarterly other long-term assets increased from Sep. 2023 (¥115 Mil) to Dec. 2023 (¥129 Mil) but then stayed the same from Dec. 2023 (¥129 Mil) to Mar. 2024 (¥128 Mil).

HPGC Renmintongtai Pharmaceutical's annual other long-term assets declined from Dec. 2021 (¥122 Mil) to Dec. 2022 (¥117 Mil) but then increased from Dec. 2022 (¥117 Mil) to Dec. 2023 (¥129 Mil).

HPGC Renmintongtai Pharmaceutical Other Long Term Assets Historical Data

The historical data trend for HPGC Renmintongtai Pharmaceutical's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPGC Renmintongtai Pharmaceutical Other Long Term Assets Chart

HPGC Renmintongtai Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 117.20 120.33 122.37 116.59 129.20

HPGC Renmintongtai Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.13 117.35 115.06 129.20 127.81

HPGC Renmintongtai Pharmaceutical Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Other Long Term Assets
Comparable Companies
SHSE:603520 SZSE:002644 SZSE:002688 SZSE:002940 SZSE:002923 SHSE:603669 SHSE:688799 SZSE:300485 SHSE:603676 SZSE:002900 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076
Website
http://www.sanjing.com.cn
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Executives
Yue Xian Zhi senior management
Zhang Li Jun Director

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Headlines

No Headlines